API Manufacturing
Multi-step synthesis, fermentation, and semi-synthesis of active pharmaceutical ingredients at commercial scale.
Precision Pharma delivers contract manufacturing of APIs and finished dosage forms with uncompromising quality standards — trusted by 120+ pharma companies worldwide.
Founded in 1999, Precision Pharma Manufacturing Ltd has grown from a regional API producer into one of the world's most trusted contract pharmaceutical manufacturers. Our 180,000 sq ft state-of-the-art facility houses end-to-end capabilities from early-phase development to commercial-scale production.
We partner with biotech startups, generic manufacturers, and Big Pharma alike — delivering regulatory-compliant product with the speed and flexibility that modern pharmaceutical development demands.
From API synthesis to finished dosage form, sterile manufacturing to packaging — one partner for your entire product lifecycle.
Multi-step synthesis, fermentation, and semi-synthesis of active pharmaceutical ingredients at commercial scale.
ISO Class 5-8 cleanrooms for aseptic processing of injectables, lyophilized products, and ophthalmic preparations.
Full analytical method development, validation, and stability studies supporting IND/NDA/ANDA regulatory submissions.
High-speed tablet compression, film coating, hard/soft capsule filling, and granulation with full PAT integration.
Formulation development from pre-IND through Phase III, with integrated CMC regulatory support and tech transfer.
Comprehensive QMS, batch record review, regulatory agency inspection readiness, and post-approval change management.
A structured, stage-gate development pathway that de-risks your program at every phase.
ACE inhibitors, ARBs, statins, and anti-arrhythmic compounds
Multi-kilogram to multi-tonne capabilities with full ICH Q7 compliance. DMF filing support included.
Cytotoxic oral and injectable products in dedicated containment suites
Potent compound handling to OEB-5 standards. Isolator technology and ISPE-compliant containment.
Aseptic fill/finish for vials, prefilled syringes, and lyophilized products
RABS and isolator technology. Capacity: 15 million vials/year. Full regulatory batch records.
From emerging biotechs to top-20 global pharma companies
Download our capability overview, quality manual, and regulatory compliance documentation.
Whether you need Phase I clinical batches or 100 million units of commercial supply — we're equipped and ready.